Search Results - "Kanters, S"

Aligning text mining and machine learning algorithms with best practices for study selection in systematic literature reviews by Popoff, E, Besada, M, Jansen, J P, Cope, S, Kanters, S

“…Despite existing research on text mining and machine learning for title and abstract screening, the role of machine learning within systematic literature…”
Get full text

UNMET NEED IN RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) POST‐BRUTON TYROSINE KINASE INHIBITOR (BTKI): A SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSIS by Dreyling, M., Shah, B., Wu, J., Itani, T., Zoratti, M. J., Kanters, S., Wade, S. W., Peng, W., Castaigne, J., Kloos, I., Wang, M.

Get full text

The prognostic value of progressing within 24 months of frontline chemoimmunotherapy (POD24) in relapsed/refractory (R/R) follicular lymphoma (FL)—a SCHOLAR‐5 analysis by Patel, A. R., Limbrick‐Oldfield, E. H., Kanters, S., Ray, M. D., Best, T., Ghione, P., Neelapu, S. S., Gribben, J. G., Beygi, S., Bobillo, S.

Get full text

Matching‐adjusted indirect comparison of axicabtagene ciloleucel versus mosunetuzumab in relapsed/refractory follicular lymphoma patients after 2 prior systemic treatments by Ray, M. D., Kanters, S., Beygi, S., Best, T., Wulff, J., Limbrick‐Oldfield, E. H., Patel, A. R., Oluwole, O. O.

Get full text

Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data by Ajani, J.A., Leung, L., Kanters, S., Singh, P., Kurt, M., Kim, I., Pourrahmat, M.-M., Friedman, H.S., Navaratnam, P., Reardon, G.

“…Establishing surrogate endpoints for overall survival (OS) may expedite assessment of new therapies in esophageal cancer (EC) and gastroesophageal junction…”
Get full text

Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses by Kanters, S., Mills, E.J., Thorlund, K., Bucher, H.C., Ioannidis, J.P.A.

“…There have been over 100 randomized clinical trials (RCTs) of diverse regimens of antiretroviral therapy for treatment-naïve human immunodeficiency…”
Get full text

OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL SCHOLAR‐5 STUDY by Ghione, P., Ghesquieres, H., Bobillo, S., Patel, A. R., Kanters, S., Deighton, K., Dong, H., Yang, Y., Ma, L., Limbrick‐Oldfield, E. H., Thornton Snider, J., Wade, S. W., Riberio, M. T., Sudhindra, A., Radford, J., Palomba, M. L., Gribben, J.

Get full text

Factors associated with large increases in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from the bioadvance survey by Kanters, S, Perampaladas, K, Thorlund, K

Get full text

Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors by Thorlund, K, Kanters, S, Mills, E

Get full text

The effects of excluding treatments from network meta-analysis by Mills, E, Kanters, S, Thorlund, K

Get full text

Modelling drug class effects in bayesian multiple treatment comparison meta-analysis: Applications in early and advanced parkinson's disease by Thorlund, K, Kanters, S, O'Regan, C, Mills, E

Get full text

Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes by Van Der Feen, C., Neijens, F. S., Kanters, S. D. J. M., Mali, W. P. Th. M., Stolk, R. P., Banga, J. D.

“…Aims To determine differences in the anatomic site of atherosclerosis in the lower extremity between patients with and patients without diabetes. Design…”
Get full text

Reproducibility of in vivo carotid intima-media thickness measurements : A review by KANTERS, S. D. J. M, ALGRA, A, VAN LECUWEN, M. S, BANGA, J.-D

“…The early phase of atherosclerosis can be studied by two-dimensional B-mode ultrasonography. Measurements of the combined thickness of the carotid intima and…”
Get full text

CO18 Exploring Endpoint Correlation Between Progression Free Survival (PFS) and Overall Survival (OS) in Previously Untreated Metastatic Melanoma Using Pseudo Individual Patient Data (IPD) by Kanters, S, Kurt, M, Moshyk, A, Leung, L

Get full text

Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus by Niemeijer-Kanters, S.D.J.M, Dallinga-Thie, G.M, de Ruijter-Heijstek, F.C, Algra, A, Erkelens, D.W, Banga, J.D, Jansen, H

“…A preponderance of small dense LDL particles is strongly associated with the occurrence of atherosclerotic disease. Although several studies have documented an…”
Get full text

Lipid-lowering therapy in diabetes mellitus by Niemeijer-Kanters, S D, Banga, J D, Erkelens, D W

“…Dyslipidemia emerges as an important modifiable risk factor for cardiovascular disease in diabetes mellitus, especially as part of the metabolic syndrome in…”
Get more information

Intensive lipid-lowering strategy in patients with diabetes mellitus by Kanters, S. D. J. M., Algra, A., De Bruin, T. W. A., Erkelens, D. W., Banga, J. -D.

“…Summary Aims To assess the feasibility of an intensive lipid‐lowering strategy in diabetic subjects pursuing target plasma lipid levels. Methods Patients with…”
Get full text

P49 Evaluation of Surrogate Endpoints (SES) for Previously Untreated Unresectable or Metastatic Melanoma (MMEL): Analyses from a Longitudinal Electronic Health Record Database in the United States (US) by Leung, L., Mohr, P., Serafini, P., Kanters, S., Pourrahmat, M.M., Moshyk, A., Srinivasan, S., Kurt, M.

Get full text

Molecular and biological factors in the prognosis of non-small cell lung cancer by Kanters, SD, Lammers, JW, Voest, EE

“…For patients with non-small cell lung cancer the tumour/node/metastasis (TNM) staging system and other conventional prognostic factors fail to predict the…”
Get full text

Carotid intima-media thickness in hyperlipidemic type I and type II diabetic patients by KANTERS, S. D. J. M, ALGRA, A, BANGA, J.-D

“…Carotid intima-media thickness in hyperlipidemic type I and type II diabetic patients. S D Kanters , A Algra and J D Banga Department of Internal Medicine,…”
Get full text